Articles From: Clearwire Corporation Provides Transaction Update to Cleveland BioLabs to Present at 15th Annual BIO CEO and Investor Conference


2013/2/1
BELLEVUE, Wash., Feb.
Sign-up for Clearwire Corporation Provides Transaction Update investment picks
2013/3/28
BELLEVUE, Wash., March 28, 2013 (GLOBE NEWSWIRE) -- Clearwire (NASDAQ: CLWR) today announced that it has elected to take the $80 million April draw under the terms of its agreements with Sprint Nextel Corporation ("Sprint") that provide additional financing to Clearwire in the form of exchangeable notes, which will be exchangeable under certain conditions for Clearwire common stock at $1.50 per share, subject to adjustment under certain conditions (the "Sprint Financing Agreements").  The Special Committee has not made any determination as to whether to take any future draws under the Sprint Financing Agreements and has not made any determination to change its recommendation of the current Sprint transaction.
Sign-up for Clearwire Corporation Provides Transaction Update investment picks
2013/2/28
Reliable and Secure Low-Cost 4G Wireless Broadband for Primary and Backup Internet Connections Range of Features Include Unlimited 1 Data, No Overage Fees, Cloud-Based Management, 24/7 Advanced Technical Support and More BELLEVUE, Wash., Feb.
Sign-up for Clearwire Debuts New CLEAR(R) Professional Service for Small and Midsized Businesses investment picks
2013/5/22
A group of Clearwire Corp.
Sign-up for Clearwire Investors See New Sprint Offer as Too Low investment picks
2013/1/31
BELLEVUE, Wash., Jan.
Sign-up for Clearwire Launches Red Hot Hotspot investment picks
2013/4/25
Clearwire Corp.'s (CLWR) first-quarter loss widened as the financially struggling wireless broadband provider saw its revenue slip and total subscriber rolls fall.
Sign-up for Clearwire Loss Widens Amid Revenue Decline investment picks
2013/5/6
BELLEVUE, Wash., May 6, 2013 (GLOBE NEWSWIRE) -- Clearwire (Nasdaq:CLWR) today mailed a letter to stockholders regarding its proposed transaction with Sprint Nextel Corporation ("Sprint"). The letter describes the proposed transaction with Sprint as providing the best strategic alternative for Clearwire's minority stockholders, representing fair, attractive and certain value.
Sign-up for Clearwire Mails Letter to Stockholders Stating Proposed Transaction With Sprint Provides Best Strategic Alternative for Clearwire's Minority Stockholders investment picks
2013/5/13
BELLEVUE, Wash., May 13, 2013 (GLOBE NEWSWIRE) -- The Board of Directors of Clearwire (Nasdaq:CLWR) ("Clearwire" or the "Company") today mailed a letter to stockholders in connection with its proposed transaction with Sprint recommending that stockholders vote 'FOR' the proposed transaction.
Sign-up for Clearwire Mails Letter Urging Stockholders to Vote 'For' Proposed Transaction With Sprint investment picks
2013/5/21
Bellevue, Wash., May 21, 2013 (GLOBE NEWSWIRE) -- Clearwire Corporation (NASDAQ: CLWR) ("Clearwire" or the "Company") today confirmed that it has received a revised offer from Sprint (NYSE:S) to acquire the approximately 50 percent stake in the Company it does not currently own for $3.40 per share.
Sign-up for Clearwire Receives Increased Offer from Sprint investment picks
2013/5/6
Clearwire Corp.
Sign-up for Clearwire Reiterates Sprint Deal Is Best Option for Minority Shareholders investment picks
2013/5/16
Reiterates Recommendations of Two Leading Proxy Advisory Firms – ISS and Egan-Jones – to Vote 'FOR' Proposed Transaction with Sprint BELLEVUE, Wash., May 16, 2013 (GLOBE NEWSWIRE) -- Clearwire (Nasdaq:CLWR) ("Clearwire" or the "Company") today issued the following open letter to stockholders: Dear Clearwire Stockholder: Time is short, as the Clearwire Special Meeting of Stockholders is just days away.
Sign-up for Clearwire Reminds Stockholders to Vote the White Proxy Card Today investment picks
2013/4/25
Q1 Total Revenues of $318.0 Million Increased 2% Sequentially, Down 1% Year Over Year Retail Subscribers Up 8% Sequentially and 10% Year Over Year on Record Gross Additions Approximately 1,300 TDD-LTE Sites Commissioned at Quarter-End; On Track to Meet 2,000 Site Milestone by End of June 2013 BELLEVUE, Wash., April 25, 2013 (GLOBE NEWSWIRE) -- Clearwire Corporation (Nasdaq:CLWR) , a leading provider of 4G wireless broadband services in the U.S., today reported its financial and operating results for first quarter 2013.
Sign-up for Clearwire Reports First Quarter 2013 Results investment picks
2013/2/12
Full Year Revenues of $1.26 Billion, Up 1%; Full Year Retail Revenues Up 5% to $795.6 Million Total Ending Subscribers of 9.6 Million, Down 8% Year Over Year From 10.4 Million 2012 Adjusted EBITDA Loss Improved by $157.0 Million Year Over Year to $(156.9) Million BELLEVUE, Wash., Feb.
Sign-up for Clearwire Reports Fourth Quarter and Full Year 2012 Results investment picks
2013/5/29
Company Criticizes Glass Lewis' Analysis as Fundamentally Flawed and Inaccurate BELLEVUE, Wash., May 29, 2013 (GLOBE NEWSWIRE) -- Clearwire Corporation (Nasdaq:CLWR) ("Clearwire" or the "Company") today issued a statement in response to the recent Glass, Lewis & Co.
Sign-up for Clearwire Says Glass Lewis Reached Wrong Conclusion investment picks
2013/5/6
Clearwire Corp.
Sign-up for Clearwire Says Sprint Deal Best for Minority Shareholders investment picks
2013/4/23
-- Clearwire to hold a special shareholders meeting May 21 to vote on proposed merger with Sprint --Crest encourages board to consider debt-financing offers from Crest and Aurelius Management Capital LP --Crest says offers from itself and Aurelius are more favorable and less "coercive" to shareholders than Sprint's financing program Investment firm Crest Financial Ltd.
Sign-up for Clearwire Sets Date for Vote on Sprint Bid investment picks
2013/5/3
Some Clearwire Corp.
Sign-up for Clearwire Shareholders to Press for Higher Buyout investment picks
2013/5/21
BELLEVUE, Wash., May 21, 2013 (GLOBE NEWSWIRE) -- Clearwire Corporation (NASDAQ: CLWR) ("Clearwire" or the "Company") today announced that it has rescheduled the date of its upcoming Special Meeting of Stockholders, which will now be held on Friday, May 31, 2013, at 10:30 a.m. Pacific time at the Highland Community Center, 14224 Bel-Red Road, Bellevue, Wash 98007.
Sign-up for Clearwire Special Meeting of Stockholders Rescheduled for May 31, 2013 investment picks
2013/4/22
BELLEVUE, Wash., April 22, 2013 (GLOBE NEWSWIRE) -- Clearwire Corporation (NASDAQ:CLWR) plans to announce its first quarter 2013 financial results on Thursday, April 25, 2013.
Sign-up for Clearwire to Host First Quarter 2013 Financial Results Conference Call investment picks
2013/5/22
Clearwire Corp.
Sign-up for Clearwire: No Substantive Talks With Dish Network Since April investment picks
2013/5/22
Follows Review and Recommendation of Special Committee of the Board Offers Fair, Attractive and Certain Value Special Meeting of Stockholders to Reconvene May 31, 2013 BELLEVUE, Wash., May 22, 2013 (GLOBE NEWSWIRE) -- Clearwire Corporation (Nasdaq:CLWR) ("Clearwire" or the "Company") today announced that its Special Committee of the Board of Directors and its Board of Directors have each approved the revised offer from Sprint (NYSE:S) to acquire the approximately 50 percent stake in the Company it does not currently own for $3.40 per share.
Sign-up for Clearwire's Board of Directors Recommends Stockholders Vote 'FOR' Increased Offer From Sprint investment picks
2013/5/30
BELLEVUE, Wash., May 30, 2013 (GLOBE NEWSWIRE) -- Clearwire Corporation (NASDAQ: CLWR) ("Clearwire" or the "Company") today acknowledged that DISH Network Corporation (NASDAQ: DISH) ("DISH") has commenced an unsolicited cash tender offer to acquire all outstanding common shares of Clearwire at a price of $4.40 per share.
Sign-up for Clearwire's Special Committee to Review Unsolicited Tender Offer from DISH investment picks
2013/4/2
BUFFALO, N.Y., April 2, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) and Incuron, LLC, a joint venture between the Company and Bioprocess Capital Ventures, today announced the receipt of a Notice of Allowance from the U.S. Food and Drug Administration (FDA) for an Investigational New Drug (IND) application for CBL0137.
Sign-up for Cleveland BioLabs and Incuron Announce Notice of Allowance From FDA to Commence Clinical Testing With CBL0137 investment picks
2013/5/14
BUFFALO, N.Y., May 14, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) and Incuron, LLC, a joint venture between the Company and Bioprocess Capital Ventures, today announced the receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for the Curaxin U.S. Patent Application Number 12/993,018, titled "Inducing Cell Death by Inhibiting Adaptive Heat Shock Response." This patent was recently issued in the Russian Federation, as well.
Sign-up for Cleveland BioLabs and Incuron Announce US and European Patent Allowances for Curaxins investment picks
2013/5/8
BUFFALO, N.Y., May 8, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that its board of directors has appointed a shareholder representative, Randy S.
Sign-up for Cleveland BioLabs Announces Appointment of Shareholder Representative to Board investment picks
2013/4/23
BUFFALO, N.Y., April 23, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that its board of directors has appointed Julia Brown and Anthony Principi as new independent directors and David Hohn, M.D., a current director, as Chairman of the board.
Sign-up for Cleveland BioLabs Announces Changes to Board of Directors investment picks
2013/5/9
BUFFALO, N.Y., May 9, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today reported financial results and development progress for the first quarter ended March 31, 2013.
Sign-up for Cleveland BioLabs Reports First Quarter 2013 Financial Results and Development Progress investment picks
2013/3/14
BUFFALO, N.Y., March 14, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today reported financial results and development progress for the fourth quarter and fiscal year ended December 31, 2012.
Sign-up for Cleveland BioLabs Reports Fourth Quarter and Fiscal 2012 Financial Results and Development Progress investment picks
2013/4/8
BUFFALO, N.Y., April 8, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) announced today the appointment of key clinical development and regulatory affairs executives to optimally position the company for successful development of its drug candidates.
Sign-up for Cleveland BioLabs Strengthens Clinical Development Team investment picks
2013/2/5
BUFFALO, N.Y., Feb.
Sign-up for Cleveland BioLabs to Present at 15th Annual BIO CEO and Investor Conference investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Clearwire Corporation Provides Transaction Update to Cleveland BioLabs to Present at 15th Annual BIO CEO and Investor Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity